Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 2.564B
March 31, 2026 2.619B
December 31, 2025 2.589B
September 30, 2025 2.488B
June 30, 2025 2.507B
March 31, 2025 2.281B
December 31, 2024 2.175B
September 30, 2024 2.369B
June 30, 2024 2.365B
March 31, 2024 2.347B
December 31, 2023 2.412B
September 30, 2023 2.286B
June 30, 2023 2.306B
March 31, 2023 2.355B
December 31, 2022 1.508B
September 30, 2022 1.422B
June 30, 2022 1.481B
March 31, 2022 1.626B
Date Value
December 31, 2021 1.600B
September 30, 2021 1.554B
June 30, 2021 1.515B
March 31, 2021 1.501B
December 31, 2020 1.498B
September 30, 2020 1.432B
June 30, 2020 1.350B
March 31, 2020 1.194B
December 31, 2019 1.173B
September 30, 2019 1.107B
June 30, 2019 1.094B
March 31, 2019 1.080B
December 31, 2018 805.44M
September 30, 2018 803.01M
June 30, 2018 803.74M
March 31, 2018 835.58M
December 31, 2017 498.70M
September 30, 2017 506.75M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.494B
Corcept Therapeutics, Inc. 888.70M
Veru, Inc. 37.03M
Avadel Pharmaceuticals Plc 199.45M

Total Assets (Quarterly) Related Metrics